The incidence of squamous cell carcinoma of the anal canal (SCCAC) is increasing. Although standard management of SCCAC includes the use of concurrent chemotherapy and radiotherapy (chemoradiotherapy), data are lacking on potentially less morbid, alternative management strategies, such as local excision, among patients with node-negative T1 disease.
Vea el texto completo en:
Management of Stage I Squamous Cell Carcinoma of the Anal Canal
Christy Y. Chai, Hop S. Tran Cao, Samir Awad; et al. JAMA Surg. 2018;153(3):209-215. doi:10.1001/jamasurg.2017.3151
Haga un comentario: